Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 03, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The only material change disclosed is a transaction involving a connected person:
- Date: March 30, 2007
- Person: Mrs C Witty
- Action: Sale of 3,220 Ordinary Shares
- Price: GBP 13.93 per share
- Notification Date: April 02, 2007
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share sale described above.
Investor Verification Points
- Verify the total shareholding of Mrs C Witty following the sale of 3,220 shares.
- Confirm the market price of GlaxoSmithKline plc shares on March 30, 2007, to contextualize the sale price of GBP 13.93.
- Review subsequent filings to determine if this transaction was part of a broader divestment plan by management.